Effect of different LDL-apheresis methods on parameters involved in atherosclerosis

Tiberiu Hershcovici1, Vered Schechner, Jerome Orlin

  • 1Lipid Unit, and Department of Medicine A, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.

Insights

Direct LDL apheresis (DSA), direct adsorption of lipoprotein (DALI), and plasma exchange effectively reduce LDL cholesterol in severe hypercholesterolemia. DALI showed the highest LDL removal, while plasma exchange was least effective.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Technology

Background:

  • Severe hypercholesterolemia requires effective LDL reduction strategies.
  • Apheresis methods offer an alternative for patients unresponsive to drug therapy.

Purpose of the Study:

  • To compare the effectiveness of three LDL apheresis methods: direct LDL apheresis (DSA), direct adsorption of lipoprotein (DALI), and plasma exchange.
  • To evaluate the impact of these procedures on blood parameters linked to atherogenesis.

Main Methods:

  • Six patients with severe hypercholesterolemia underwent sequential apheresis treatments.
  • Treatments included plasma exchange, DSA, and in some cases, DALI.
  • Lipoprotein levels, apoproteins, CRP, homocysteine, fibrinogen, and blood counts were measured pre- and post-treatment.

Main Results:

  • All three apheresis methods significantly reduced total cholesterol and ApoB-lipoproteins.
  • DALI demonstrated the highest efficacy in LDL removal.
  • Significant reductions in triglycerides, HDL, and ApoA1 were observed across all methods.
  • DSA and DALI led to a greater reduction in HDL-C than previously reported.
  • The LDL/HDL-cholesterol ratio decreased with DSA and DALI, but increased with plasma exchange.
  • CRP, fibrinogen, and platelets decreased with all methods; homocysteine decreased with DSA and DALI only.

Conclusions:

  • All tested apheresis procedures effectively reduce atherogenic compounds.
  • DALI is the most effective LDL apheresis method among those studied.
  • Plasma exchange is nonselective and not recommended as the primary apheresis choice for hypercholesterolemia.